Colospa: Targeted Relief for Irritable Bowel Syndrome Discomfort
Colospa
| Product dosage: 135mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.98 | $59.00 (0%) | 🛒 Add to cart |
| 90 | $0.93 | $88.50 $84.00 (5%) | 🛒 Add to cart |
| 120 | $0.92 | $118.00 $110.00 (7%) | 🛒 Add to cart |
| 180 | $0.89 | $177.00 $160.00 (10%) | 🛒 Add to cart |
| 270 | $0.87 | $265.50 $235.00 (11%) | 🛒 Add to cart |
| 360 | $0.86
Best per pill | $354.00 $311.00 (12%) | 🛒 Add to cart |
Synonyms
| |||
Colospa (mebeverine hydrochloride) is an antispasmodic agent specifically formulated for the symptomatic management of Irritable Bowel Syndrome (IBS). It functions as a direct smooth muscle relaxant, acting predominantly on the gastrointestinal tract to alleviate spasmodic pain and cramping without affecting normal gut motility. By targeting the underlying muscle hyperactivity responsible for discomfort, Colospa provides focused relief, helping to restore daily comfort and function for individuals affected by IBS. Its selective action minimizes systemic side effects, making it a well-tolerated option for long-term symptom control.
Features
- Contains mebeverine hydrochloride 135 mg per tablet
- Selective antispasmodic action on gastrointestinal smooth muscle
- Does not inhibit normal peristalsis
- Film-coated tablet for ease of swallowing
- Suitable for adults and adolescents over 12 years of age
- Available in packs of 20, 50, or 100 tablets
Benefits
- Effectively reduces abdominal cramping and pain associated with IBS
- Minimizes bloating and discomfort without causing constipation
- Allows resumption of normal daily activities with reduced symptom interference
- Does not induce drowsiness or central nervous system effects
- Supports long-term management of functional bowel disorders
- Improves quality of life by targeting primary IBS symptoms
Common use
Colospa is primarily indicated for the symptomatic treatment of Irritable Bowel Syndrome (IBS), including relief of abdominal pain, spasms, and bloating. It is also used in the management of other functional gastrointestinal disorders characterized by smooth muscle spasm. It is not intended for the treatment of organic bowel diseases or acute inflammatory conditions.
Dosage and direction
The recommended dosage for adults and adolescents over 12 years is one tablet (135 mg) three times daily, preferably taken 20 minutes before meals. Tablets should be swallowed whole with water and not chewed or crushed. Dosage may be adjusted based on clinical response, but should not exceed three tablets per day. Treatment is usually continued until symptoms resolve; long-term use may be appropriate under medical supervision.
Precautions
Use with caution in patients with known hypersensitivity to mebeverine or any excipients. Although rare, patients should be monitored for paradoxical worsening of symptoms. Not recommended during pregnancy unless clearly needed, as safety data is limited. Breastfeeding women should consult their physician before use. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency, or glucose-galactose malabsorption should not take this medicine.
Contraindications
Hypersensitivity to mebeverine hydrochloride or any component of the formulation. Ileus, intestinal obstruction, or severe hepatic impairment. Not indicated for children under 12 years of age. Should not be used in patients with paralytic ileus or megacolon.
Possible side effects
Common side effects (may affect up to 1 in 10 people) include mild dizziness, headache, or nausea. Uncommon side effects (may affect up to 1 in 100 people) include skin rash, urticaria, or angioedema. Rare cases of anaphylactic reactions have been reported. Most side effects are mild and transient, typically resolving with continued use or dosage adjustment.
Drug interaction
No clinically significant interactions with other medications have been established. However, as with any medication, patients should inform their healthcare provider about all concomitant medications, including over-the-counter drugs and herbal supplements. Theoretical potential for interaction with other anticholinergic agents exists, though mebeverine has minimal systemic anticholinergic effects.
Missed dose
If a dose is missed, take it as soon as remembered unless it is nearly time for the next dose. Do not double the dose to make up for a missed one. Continue with the regular dosing schedule. Consistent dosing before meals provides optimal therapeutic effect.
Overdose
Symptoms of overdose may include nervousness, agitation, or cardiovascular effects. No specific antidote exists. Treatment should be symptomatic and supportive. Gastric lavage may be considered if ingestion occurred recently. Patients should seek immediate medical attention if overdose is suspected.
Storage
Store below 30°C in the original packaging to protect from moisture. Keep out of reach of children. Do not use after the expiration date printed on the packaging. Do not dispose of medication in wastewater or household waste; return unused medication to pharmacy for proper disposal.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting any new medication. Individual response to treatment may vary. Proper diagnosis by a qualified medical practitioner is essential before initiating therapy.
Reviews
Clinical studies demonstrate Colospa’s efficacy in reducing IBS symptoms, with patients reporting significant improvement in pain scores and quality of life measures. Many users report rapid relief of cramping within days of initiation. Healthcare providers appreciate its favorable safety profile and targeted mechanism of action. Long-term users note consistent symptom control with minimal side effects, though individual experiences may vary based on symptom severity and adherence to dosage instructions.